| Hans-Günter Meyer-Thompson | Naloxon
U.S. Naloxone Report Highlights The Competitive Scenario With Impact Of Drivers And Challenges 2030 | Novartis AG, Indivior Plc., ADAPT Pharma, Inc., Amphastar Pharmaceuticals, Inc., INSYS Therapeutics, Inc.
U.S. Naloxone Report Highlights The Competitive Scenario With Impact Of Drivers And Challenges 2030 | Novartis AG, Indivior Plc., ADAPT Pharma, Inc., Amphastar Pharmaceuticals, Inc., INSYS Therapeutics, Inc.
(digitaljournal.com, USA, 09.06.2023)
https://www.digitaljournal.com/pr/news/coherent-market-insights/u-s-naloxone-report-highlights-the-competitive-scenario-with-impact-of-drivers-and-challenges-2030-novartis-ag-indivior-plc-adapt-pharma-inc-amphastar-pharmaceuticals-inc-insys-therapeutics-inc-